A $55,000 drug that doesn’t cure Alzheimer’s
Today, Explained
00:00
The Costly Controversy of Alzheimer’s Treatment
This chapter explores the approval process and controversies surrounding a high-cost drug for Alzheimer's disease, examining its efficacy and safety. It also highlights the financial implications and the broader issues within the healthcare system tied to the drug's market introduction.
Transcript
Play full episode
